Press release
Deadline on April 8th in Lawsuit for Investors in Biogen Inc. (NASDAQ: BIIB) coming up
A Deadline is coming up on April 8, 2022 in the lawsuit for certain investors in Biogen Inc. (NASDAQ: BIIB) and Biogen Inc. (NASDA
Investors who purchased shares of Biogen Inc. (NASDAQ: BIIB) have certain options and there are strict and short deadlines running. Deadline: April 8, 2022. NASDAQ: BIIB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Massachusetts the plaintiff alleges on behalf of purchasers of Biogen Inc. (NASDAQ: BIIB) common shares between June 7, 2021 and January 11, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 7, 2021 and January 11, 2022, the Defendants made materially false and/or misleading statements and/or failed to disclose that there was a significant, undisclosed lobbying campaign between Biogen and the Food and Drug Administration ("FDA") that was instrumental in the decision to file and approve Aduhelm, a drug being developed to treat Alzheimer's disease, that the Phase III ENGAGE study demonstrated that Aduhelm failed to achieve a clinical benefit to Alzheimer's patients, that ENGAGE was a failed study from which Biogen concluded not to seek FDA approval for Aduhelm in 2019, and that defendants misled investors as to the way in which approval was achieved, that the clinical data did not support a clinical benefit by taking Aduhelm and that side-effects were dangerous and serious.
Those who purchased shares of Biogen Inc. (NASDAQ: BIIB) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on April 8th in Lawsuit for Investors in Biogen Inc. (NASDAQ: BIIB) coming up here
News-ID: 2584199 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Biogen
Tysabri Market to Witness Comprehensive Growth by 2032 | Biogen
The latest Research report published by Coherent Market Insights with the title An Increase in Demand and Opportunities for Global Tysabri Market 2025 provides a sorted image of the Tysabri industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making an ongoing impact on the global economy. The report presents…
Antirheumatics Pharmaceutical Market is Booming Worldwide |Biogen,AstraZeneca,Te …
HTF MI just released the Global Antirheumatics Pharmaceutical Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Antirheumatics Pharmaceutical Market are: Pfizer, AbbVie, Johnson…
Autoinjectors Market Growth Outlook Beyond 2024 | AstraZeneca, Biogen, Sanofi
HTF MI recently introduced Global Autoinjectors Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study Eli Lilly, Mylan, Amgen, Ypsomed, Teva Pharmaceuticals, AbbVie, AstraZeneca, Biogen, Sanofi, Novartis, Bayer, Merck, SHL…
Systemic Lupus Erythematosus Market to Rise by 2034 | GlaxoSmithKline, AstraZene …
DelveInsight's "Systemic Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Lupus Erythematosus, historical and forecasted epidemiology as well as the Systemic Lupus Erythematosus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Systemic Lupus Erythematosus market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Systemic Lupus Erythematosus Drug Market Report 2034: Epidemiology, Latest FDA A …
DelveInsight's "Systemic Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Systemic Lupus Erythematosus, historical and forecasted epidemiology as well as the Systemic Lupus Erythematosus market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Discover which therapies are expected to grab the Systemic Lupus Erythematosus market share @ Systemic Lupus Erythematosus Market Outlook Report- https://www.delveinsight.com/sample-request/systemic-lupus-erythematosus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Europe Anaerobic Digestion Market Analysis Focusing on Top Key Players Biogen, C …
Market Study Report adds Europe Anaerobic Digestion market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years.
The Netherlands in 2016, accounted for over 4% annual capacity share across the Europe anaerobic digestion market. Cost competitive deployment of AD systems when compared to landfill and incineration based plants will appreciably drive the industry…
